Nasopharyngeal Cancer

Our head and neck specialists offer evidence-based, compassionate care for people with nasopharyngeal cancer, which affects the nasopharynx, located at the top part of the throat. Through our clinical trials, we offer access to new imaging techniques that help your doctors diagnose nasopharyngeal cancer and guide treatment decisions. Then, our team of radiation oncologists, medical oncologists, and other experts develops a personalized care plan that’s right for you.

Clinical Trials and Research Studies

Phase 1

A Phase 1 Open-Label Multicenter Study to Assess the Safety Tolerability and Immunogenicity of mRNA-4157 Alone in Subjects with Resected Solid Tumors and in Combination with Pembrolizumab in Subjects with Unresectable Solid Tumors

Learn More

Phase 1

A Phase 1 Open-Label Dose-Escalation and Cohort Expansion First-in-Human Study of the Safety Tolerability Activity and Pharmacokinetics of REGN3767 (anti-LAG-3 mAb) Administered Alone or in Combination with REGN2810 (anti-PD-1 mAb) in Patients with Ad

Learn More

Phase 2/3

Randomized Phase Ii And Phase Iii Studies Of Individualized Treatment For Nasopharyngeal Carcinoma Based On Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)

Learn More

Phase N/A

Assessment of treatment response of nasopharyngeal cancer using simultaneous 18F-FDG-PET and MRI

Learn More